OIRD in hospitalized patients is Atelerix’s first target indication for opioid-related unmet medical needs.
* Source: Medtronic Prodigy Study, 2020
– National Institutes of Health
Russian special forces soldiers are seen carrying out hostages killed by a highly potent weaponized opioid in a Moscow theatre after a three-day stand off with Chechen terrorists.
(Credit: Anton Denisov/AFP/Getty Images)
Most ongoing research to minimize opioid-induced side effects is focused on direct targeting of opioid receptors – these efforts have largely not been successful.